Interconnected epidemics: obesity, metabolic syndrome, diabetes and cardiovascular diseases—insights from research and prevention strategies

The global surge in obesity, metabolic syndrome (MetS), and diabetes has led to a heightened prevalence of cardiovascular diseases (CVDs), posing a major public health challenge. This short communication outlines contemporary research approaches addressing the association between these interconnected conditions. Epidemiological studies, such as the Framingham Heart Study and INTERHEART, have confirmed the strong link between obesity, MetS, and diabetes as predictors of CVDs. Advances in genomics and biomarker discovery, including studies on adipokines and single nucleotide polymorphisms (SNPs), are providing insights into the genetic predispositions that influence the progression from obesity to metabolic disorders. Molecular research has focused on insulin resistance, endothelial dysfunction, and inflammation as key pathways driving these conditions. Furthermore, multi-omics approaches, combining genomics, proteomics, and metabolomics, are offering new opportunities for personalized interventions and precision medicine. Public health strategies, such as lifestyle interventions and policy changes, are also crucial in addressing the rising burden of these diseases. The integration of these innovative research methodologies will be essential in developing personalized treatment strategies and preventive approaches to curb the growing impact of metabolic and cardiovascular diseases.